World News
-
LabCorp, Mount Sinai HS to develop AI-enabled pathology CoE
World | News | 0 Comment | 26 Jun, 2019
LabCorp and the Mount Sinai Health System have announced another element in their shared goal of improving laboratory services and patient care. LabCorp, a life sciences company, and&n...Read more
-
New Multi-Partner Trust Fund launched to combat antimicrobial resistance globally
World | News | 0 Comment | 25 Jun, 2019
In a major boost to combat one of the gravest risks to global health a funding vehicle allowing partners to devote resources to accelerate global action against Antimicrobial Resistance (AM...Read more
-
Glenmark, Novartis to promote respiratory products in Brazil
World | News | 0 Comment | 24 Jun, 2019
Glenmark has announced that its Brazilian subsidiary, Glenmark Farmacêutica Ltda has entered into an exclusive partnership agreement with Novartis Biosciences S.A, a subsidiary of Nov...Read more
-
Parexel launches an enhanced integrated outsourcing delivery model for FSP
World | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Pfizer has announced that the European Commission approved TALZENNA (talazoparib), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, as monotherapy for the treatment of...Read more
-
Canon Medical Showcases New Ultrasound Product Line at ASE 2019
World | News | 0 Comment | 24 Jun, 2019
Canon Medical Systems USA, Inc. is showcasing its innovative new line of ultrasound systems, the Aplio a-series, at this year’s American Society of Echocardiography (ASE) annual meeti...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Vertex Pharmaceuticals Incorporated has announced that the U.S. Food and Drug Administration (FDA) approved SYMDEKO (tezacaftor/ivacaftor and ivacaftor) for use in children with cystic fibr...Read more
-
Agilent invests$185M in new facility to develop Oligos
World | News | 0 Comment | 24 Jun, 2019
Agilent Technologies Inc. has announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture "oligos," which are short DNA and RNA...Read more
-
Regeneron, Sanofi announce positive results for IL-33 antibody for asthma
World | News | 0 Comment | 21 Jun, 2019
Regeneron Pharmaceuticals and Sanofi have announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoi...Read more
-
PDS Biotechnology Corp gets U.S. and European patents for Versamune
World | News | 0 Comment | 21 Jun, 2019
PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced that the United ...Read more
-
Optum completes acquisition of DaVita Medical Group from DaVita
World | News | 0 Comment | 21 Jun, 2019
Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s leading independent medical groups, from DaVita Inc. As part of the tr...Read more
-
Servier lays foundation stone for new research institute
World | News | 0 Comment | 21 Jun, 2019
Servier, an independent international pharmaceutical company, has laid the foundation stone of its future Research Institute in the Paris-Saclay cluster. The new Servier Paris-Saclay Resear...Read more
-
Edesa Biotech receives approval to proceed with its clinical investigation
World | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investi...Read more
-
Verastem Oncology announces leadership changes
World | News | 0 Comment | 20 Jun, 2019
Verastem, a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced ...Read more
-
Novo Nordisk’ Victoza gets FDA nod to treat type 2 diabetes
World | News | 1 Comment | 20 Jun, 2019
Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Victoza® (liraglutide) injection to lower blood sugar along with...Read more
-
Gilead collaborates with Nurix to develop new cancer therapies
World | News | 0 Comment | 21 Jun, 2019
Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted protein degr...Read more
-
Genocea announces pricing of $36,750,000 public offering of common stock
World | News | 0 Comment | 20 Jun, 2019
Genocea Biosciences, a biopharmaceutical company developing personalized cancer immunotherapies has announced the pricing of its previously announced underwritten public offering of 10...Read more
-
Invivoscribe LeukoStrat CDx FLT3 Mutation Test approved for treating R/R AML with FLT3 –ITD
World | News | 0 Comment | 20 Jun, 2019
Invivoscribe, announced that on 5 June 2019, the Ministry of Health, Labour and Welfare (MHLW) approved LeukoStrat® CDx FLT3 Mutation test, as a diagnostic assistant for ...Read more
